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DIFFERING MODELS OF
ETHICS CONSULTATION AND
THEIR LIMITATIONS

n average, just three ethics
consultations are performed
per year in U.S. hospitals (Fox,
Myers & Pearlman, 2007). Given the
likelihood that your hospital will have
so few ethics consultation requests
each year, how much professional
energy should an institution expend
maintaining an ethics consultation
service? Typically, such consultations
are provided, in whole or in part,
by members of a health care ethics
committee. In Maryland, such
committees (i.e., “patient care advisory
committees”) are mandated by law.
The Joint Commission looks to ethics
committees as one mechanism for
addressing ethical issues within an
institution. But how effective is the
ethics committee in “addressing ethical
issues” at the institution it serves? And
what role should formal ethics case
consultation play in this process?
Some institutions have explored
alternatives to the types of infrequent,
conflict-laden ethics consultations
quantified by Fox and colleagues
(2007). Columbia St. Mary’s hospital
offers one example. The institution’s
staff attempted to identify patient
care situations that would benefit
from ethics consultations closer to
a patient’s hospital admission. They

predicted that such consultations
would be more advisory in nature—
that is, involving interpretations of
the Catholic Hospital Association’s
Ethical and Religious Directives, or
clarification of established hospital
ethics policy and procedures. Mark
Repenshek, PhD, Health Care Ethicist
at Columbia St. Mary’s (CSM’s)
Health System, developed a database
describing ethics consultations
performed between 2003 and 2007.
Of 179 consultations performed
during this time at CSM’s four acutecare Wisconsin hospitals (totaling
about 650 beds), “ethics advisement”
accounted for 152 of 179 total requests
(84.9%), ethics committee consultation
accounted for 24 of 179 requests
(13.4%), and retrospective case review
accounted for three of 179 requests
(1.7%). Repenshek noted that, with
increased awareness of ethics services
available, retrospective case review
is being increasingly requested—that
is, “targeted education requested
by a unit/department with the goal
of organizational process change
or development in response to the
consultation requested” (p. 12). But
more notably, the relatively low number
of formal ethics case consultations is
dwarfed by the much higher number
Cont. on page 2
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of “ethics advisements.” Is this
happening elsewhere?
A cousin to ethics advisement
might be found in the practice of
ethics rounding, which was implemented by DeRenzo and her fellow bioethicists at various MedStar
hospitals. The participation of a
bioethicist in ICU rounds brings
ethical issues to the forefront, and allows the ethics consultant to counsel
and educate health care providers at
the bedside, demonstrating utility of
ethics expertise in everyday patient
care decision-making. This increases
awareness of the ethics consult service, and achieves a more proactive
ethics intervention that may reduce
escalation of conflict that so often
typifies formal case consultations
(Derenzo, Mokwunye, & Lynch,
2006).
The upcoming second edition of
ASBH’s Core Competencies for
Health Care Ethics Consultation
considers rounding in an ICU to
be something different from ethics
consultation, both representing

one of several activities that an
ethics consultant may engage in.
Other examples include mentoring,
lecturing, scholarly writing,
policy review, etc. Many ethics
consultants also engage in “curbside
consultations.” DeRenzo and
colleagues report an increase in such
consultations in hospital corridors as
a result of the increased presence of
bioethicists at ICU rounds. The issue
of “advisory consults” or “curbside
consults,” however, raises questions
about due process, procedural
standards, and fairness.
Consider an analogy to the field
of cardiology. You are a general
internist. You ask a cardiologist
colleague a question related to
treating atrial fibrillation, because
you currently have a patient with this
condition. Your colleague gives you
a general opinion about medications
used to treat atrial fibrillation. This
is not a cardiology consult, because
your colleague has not evaluated
the patient’s medical history and
conducted a thorough exam. He or

The Maryland Healthcare Ethics Committee Network (MHECN) is a
membership organization, established by the Law and Health Care Program
at the University of Maryland School of Law. The purpose of MHECN is
to facilitate and enhance ethical reflection in all aspects of decision making
in health care settings by supporting and providing informational and
educational resources to ethics committees serving health care institutions
in the state of Maryland. The Network will achieve this goal by:
• Serving as a resource to ethics committees as they investigate
ethical dilemmas within their institution and as they strive to assist
their institution to act consistently with its mission statement;
• Fostering communication and information sharing among Network
members;
• Providing educational programs for ethics committee members, other
healthcare providers, and members of the general public on ethical
issues in health care; and
• Conducting research to improve the functioning of ethics committees
and ultimately the care of patients in Maryland.
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she has not entered a note in the
patient’s medical record. It might
meet your needs. It might not.
Similarly, if a physician asks an
ethics consultant a question about
a patient, she may be seeking general insight or information that
is not dependent on the patient’s
particular circumstances (e.g., “I’m
writing a DNR order for a patient
based on a medically ineffectiveness certification. Do I have to tell
the surrogate?”). This would be an
example of what Repenshek would
call an “ethics advisement” request,
and what Fox and colleagues (2006)
at the National Center for Ethics in
Health Care would call a “non-case
consultation” request. Or, the physician may be seeking input of the
ethics expert on a particular patient’s
plan of care (e.g., “I am thinking
of stopping Mr. W’s tube feedings
based on medical ineffectiveness. Is
this OK?”). This would be an example of a “case consultation” request.
Each should be handled by a wellinformed ethics consultant who is
mindful of how particular details of a
case may dictate ethically appropriate options. But any recommendation
or advice intended to directly influence a particular patient’s plan of
care should be approached as a “case
consultation,” in which the consultant follows a standard process (e.g.,
gathering facts, visiting the patient,
convening a meeting of stakeholders,
if indicated, entering an ethics note
in the patient’s medical record, etc.).
Given the range of alternatives to
ethics consultation described above,
one may ask whether ethics committees should look beyond formal case
consultation as the most effective
method of addressing ethical issues
at their institutions. But this raises
questions about whether ethics committees have the skills and staffing

resources necessary to implement
these alternative approaches. While
the institutions at which Repenshek
and DeRenzo are affiliated have
trained, paid ethics consultants to
staff their services, Fox and colleagues (2007) found that only 16%
of hospitals provide salary support
specifically for ethics consultation.
Many think hospitals would be better
off making a financial commitment
to support ethics consultation at their
institutions. Ethics consultation is
best positioned to produce value for
a health care organization when it
is more readily accessible to health
care providers at the bedside, and
when it is provided by qualified ethics consultants. Providing services
beyond mere case consultation, such
as those described above, could
improve staff morale and perceptions
regarding the ethical climate of the
organization, lower perceived moral
distress among staff, lower staff
turnover, improve palliative care
access and outcomes among patients,
and reduce resources spent on nonbeneficial interventions.1 Perhaps
hospital administrators and ethics
committee members are content with
the status quo provided by the majority of all-volunteer, low volume
ethics consultation services, rather
than considering the value added
from providing the other types of
ethics services described above. Or,
perhaps all-volunteer ethics committees are capable of branching out to
provide such services with adequate
training and leadership support. But
it’s more likely that the positive
impact of health care ethics committees and ethics consult services will
be the greatest for those institutions
whose budgets support a range of
services that address ethical issues
throughout the institution.
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Note
Repenshek and colleagues were
able to show that hospital length of
stay was reduced by half for patients
who had an ethics consultation (from
36.1 days in 2003 to 18.23 days in
2007). Schneiderman and colleagues
had similar findings; Schneiderman,
et al. (2003), “Effect of ethics
consultations on non-beneficial
life-sustaining treatments in the
intensive care setting: A randomized
controlled trial.” JAMA 290, 11661172.
1
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ASBH TO RELEASE 2ND EDITION
OF CORE COMPETENCIES

n February, 2006, the American
Society for Bioethics and
Humanities (ASBH) Board
approved a motion to produce
an updated version of the Core
Competencies for Health Care
Ethics Consultation. The Core
Competencies Update Task Force
was formed for this purpose.
From November, 2009 through
January 31, 2010, a draft of the 2nd
edition of the Core Competencies
was publicly available for open
comment at http://www.asbh.org.
Feedback is now being reviewed
and, where necessary, changes are
being made to the final draft. The
newly formed ASBH Standing
Committee on Clinical Ethics
Consultation Affairs will review
the final draft later this year, and
provide a recommendation that
the ASBH Board approve it for
publication.
Major changes from the first
edition, which was published in
1998, include:
1. Boundaries of Health Care
Ethics Consultation (HCEC)
clarified. HCEC was distinguished
from other activities typically
performed by health care ethicists,
such as developing ethics-related
organizational policies, serving
on organizational committees, and
producing scholarly work. This
decision was based on a shared
understanding that the competencies
required for ethics consultation
are different from competencies
required for these other activities.
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2. Scope of HCEC clarified. The
2nd edition clarifies that HCEC is
not necessarily limited to what is
often thought of as clinical ethics
(e.g., issues relating to end-of-life
care), but may encompass a broad
range of content domains including,
for example, ethical practices in
resource allocation, business and
management, and research. Clinical
ethics, organizational ethics,
professional ethics, business ethics,
research ethics, medical ethics,
and the like, are thus depicted as
“sub-specialties” of health care
ethics, in recognition of the fact that
some health care ethics consultants
will limit their practice to one or
more of these areas, while other
ethics consultants may respond to
questions across the full spectrum
of health care ethics.
3. Content related to “organizational ethics” integrated into Section
1. The 2nd edition no longer recognizes “clinical ethics” and “organizational ethics” as distinct entities.
The decision was made to eliminate
this distinction because of both the
wide divergence of opinion regarding the meaning of these terms, and
recognition of the increasing trend
to integrate ethics throughout an organization. Thus, content related to
“non-case consultations” was added
to Section 1, as well as how the ethics consultation service collaborates
with other services within a health
care institution.

4. Distinction made between
“case” and “non-case” consultations. The 2nd edition divides
HCECs into two mutually exclusive
categories: ethics consultations that
pertain to a specific, active patient
case (referred to as “case consultations”) and all other ethics consultations (“non-case consultations”).
The Task Force considered a variety
of different alternatives for categorizing ethics consultation activities
and engaged in lengthy discussions
before ultimately deciding to adopt
the “case/non-case” terminology.*
The rationale for this decision was
that the process that should be used
by an ethics consultant—and therefore the specific competencies required—hinges on whether the ethics consultation involves a question
about a specific, active patient case,
or instead involves a more general
question such as how to interpret an
ethics-related policy, how to understand a particular ethics topic, or
how to analyze a hypothetical or a
historical (inactive) patient case.
5. Ethics facilitation approach
clarified. Content related to the
ethics facilitation approach to
HCEC was clarified. For example,
giving recommendations, sharing
expertise, and use of mediation
skills are consistent with an ethics
facilitation approach. The term
“pure facilitation” was replaced
with “pure consensus” to more
accurately describe the approach
involving group agreement
regardless of adherence to ethical
standards.

6. Emerging ethics consultation
service providers recognized.
Newer models of ethics consultation
services are briefly mentioned,
such as regional ethics networks,
consortia, and remote access
services.
7. Emerging HCEC service and
consultation process standards
added. The 2nd edition adds
a new section on emerging
process standards for HCEC—for
example, having a policy on ethics
consultation that specifies open
access and a defined process for
approaching a case consultation,
such as holding a formal meeting
with involved stakeholders (if
appropriate), notifying the attending
physician (if he/she was not aware
that an ethics consultation was
requested), and documenting
the ethics consultation. This was
thought appropriate given the
evolution of the field over the years
since the first edition of the Core
Competencies report was published.
8. Skills table expanded. The
following competencies were
added to the ethics consultation
skills table: quality improvement
and evaluative skills; the ability
to communicate and collaborate
effectively with other responsible
individuals, departments, or
divisions within the institution; and
the ability to access relevant ethics
literature, policies, and guidelines.

9. Section on evaluating ethics
consultations expanded. Section 3
describes approaches to evaluating
the quality (i.e., structure, process,
and outcomes), access, and
efficiency of an ethics consultation
service. Where available, examples
of empirical data on ethics
consultation relating to each
component are presented, as well
as published tools to evaluate that
component. Recommendations for
evaluating and improving ethics
consultation and priorities for future
research are presented.
10. “Character” changed to
“attributes.” The content describing
character traits that are desirable in
ethics consultants was changed to
“attributes, attitudes, and behaviors”
of ethics consultants, as this is
common language that health
professions use to describe the
behavioral component of practice.

11. Ethical obligations and
components of a code of ethics
added. Based on efforts underway
at the time of this publication to
develop a code of ethics for health
care ethics consultants, ethical
obligations of such consultants are
presented, along with implications
for those functioning as professional
ethics consultants.
* Resources from the VA’s
National Center for Ethics in Health
Care are prominently featured
in the 2nd edition of the Core
Competencies. In many instances,
no other published resources were
located that were as comprehensive
as the VA’s. Of note, the staff at
VA’s National Center for Ethics
conducted a rigorous consensus
development process that included
systematic reviews and extensive
input from multiple ASBH members
representing many different
organizations.

The American Society for Bioethics and Humanities (ASBH)
was founded in January 1998 through the consolidation of three
existing associations in the field: the Society for Health and
Human Values (SHHV), the Society for Bioethics Consultation
(SBC), and the American Association of Bioethics (AAB).
ASBH serves to promote the exchange of ideas and foster
multidisciplinary, interdisciplinary, and inter-professional
scholarship, research, teaching, policy development, and
professional development among people engaged in bioethics
and the health-related humanities. ASBH’s Clinical Ethics
Consultation Affinity Group (CECAG) offers opportunities for
individuals involved in clinical ethics to collaborate and share
information. For more information about ASBH and CECAG,
visit http://www.asbh.org.
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CASE PRESENTATION

O

ne of the regular features of this
Newsletter is the presentation
of a case considered by an ethics
committee and an analysis of the
ethical issues involved. Readers are
both encouraged to comment on the
case or analysis and to submit other
cases that their ethics committee has
dealt with. In all cases, identifying
information about patients and others
in the case should only be provided
with the permission of the patient.
Unless otherwise indicated, our
policy is not to identify the submitter
or institution. Cases and comments
should be sent to MHECN@law.
umaryland.edu, or MHECN, Law &
Health Care Program, University
of Maryland School of Law, 500 W.
Baltimore St., Baltimore, MD 21201.

CASE FROM A
MARYLAND
HOSPITAL*

G

B is a woman with Stage
IV cervical carcinoma that
has spread to her lungs.
She was so ill from her underlying
disease that she was not considered a
candidate for further chemotherapy.
While she was hospitalized, three of
her physicians spoke with her about
the futility of further treatment and
advised her to enter hospice care. All
three physicians documented in her
chart the futility of further treatment
other than comfort care. She
refused all consideration of Do Not
Resuscitate/Do Not Intubate status.
Upon discharge from the hospital,
one of her physicians requested an
ethics consultation out of concern
that the patient was unrealistic about
her medical condition. This physician
wished to warn the emergency room
(ER) staff about GB’s possible return
6 Mid-Atlantic Ethics Committee Newsletter

to the ER in extremis, believing that
attempts at full resuscitation would
be inappropriate and would actually
cause her more pain and suffering.

COMMENTS FROM
A GERIATRICIAN

T

o my knowledge, there are no
data available regarding how
often physicians in Maryland
utilize the provisions of the State's
Health Care Decisions Act (HCDA)
that allow a medical intervention to
be withheld if two physicians certify
that it is medically ineffective for
a given patient (Sections 5-601 (n)
and 5-611 (b)). The Act defines a
procedure to be medically ineffective
if “to a reasonable degree of
medical certainty, it will not prevent
or reduce the deterioration of the
health of an individual or prevent the
impending death of an individual.”
Orders for cardiac resuscitation
procedures, commonly referred to as
“Code Status Orders,” are typically
written after discussion with the
patient or surrogate decision maker,
or upon review of the patient’s
advance directives. The order either
to attempt or withhold resuscitation
efforts is usually entered with the
consent of the patient him or her
self, the surrogate decision maker
or upon the authority of the valid
written advance directive. How often
physicians and patients disagree
on whether cardiac resuscitation
should be attempted is unknown.
Generally, in today’s medicallegal world, physicians will write
“Full Code Status” orders at the
request or insistence of the patient
or surrogate decision maker, even
when the physician believes Cardio-

Pulmonary Resuscitation (CPR)
to be an ineffective procedure for
saving the patient’s life. This reflects
either the physician’s desire to
respect the patient’s autonomous
decision making, or to avoid the risk
of potential legal action for writing
a Do Not Resuscitate (DNR) order
against the patient’s wishes, and/
or uncertainty about what really
constitutes medical ineffectiveness
in a legal sense. To my knowledge,
no physician in Maryland has
ever been sued for using medical
ineffectiveness criteria for entering
a DNR order against the expressed
wishes of a patient or surrogate or
written directive. But there is little
comfort in this fact since, although
there have been no prior lawsuits,
there is fear of being the first case.
There are anecdotal reports of
hospital administrators, acting out
of fear of legal action, preventing
physicians from using medical
ineffectiveness criteria to withhold
requested treatment, even when the
physician’s decision was supported
by the deliberations of the hospital
ethics committee. Data on the
frequency of this sort of occurrence
are lacking.
In the case presented above, the
ethics committee was not asked
to comment on the ethics of using
medically ineffective criteria for
withholding CPR against the wishes
of the patient, but rather on whether
the medically ineffective “No CPR”
designation should be durable across
sites of care. Does the “No CPR”
order established during the acute
hospital episode have durability if
the patient should present to the
emergency department at a later
date? Does it make a difference if
this order were entered upon the

request of the patient, or rather by
two physicians certifying that CPR
would be medically ineffective?
There are concrete logistical issues
as well as ethical issues relevant to
this case.
If a patient in the community calls
for emergency response via 911,
the only way that the paramedics in
Maryland will withhold CPR efforts
is if a valid MEMS (Maryland
Emergency Medical System) DNR
form is presented. Therefore, a
patient or family member who
wishes to have CPR performed
(even if the physicians believe
it is ill advised) will simply not
present the MEMS form and CPR
will be implemented automatically,
if the patient sustains sudden
cardiac arrest in the presence of
the paramedics. Once transported
to the emergency department,
the decision to continue or cease
resuscitation efforts will most likely
depend on the patient’s response to
the initial efforts. The only way a
DNR order would be honored in a
community or ER setting would be
if the patient presented with a valid
MEMS form or personally gave the
directive herself for no resuscitation.
Logistically, if the patient was
brought to the Emergency
Department and was able to request
full code status, the Emergency
Department physician would not
likely withhold CPR attempts, even
if the anticipated outcome were
death.
A study published in 2009 from
The M.D. Anderson Cancer Hospital
in Houston by Hwang et. al., reviewed all cancer patients sustaining
cardiac arrest out of hospital treated
in their emergency department between 2000 and 2002. Of the 41 patients undergoing CPR in the Emergency Department, 18 (43%) had
return of spontaneous circulation and

were admitted to the intensive care
unit. Of those 18 patients, 9 did not
survive the hospitalization and only
two (4.9%) were discharged alive to
home, the other 7 being discharged
to other institutional care, such as an
inpatient hospice or nursing facility. Short or long term survival data
on the 9 CPR survivors were not
presented. The patient may know
the literature and may think that 5%
odds are worth the attempt and argue
that 5% success rate is medically effective when compared with the 0%
success rate of doing nothing. The
physicians might argue in response
that this particular patient’s clinical
status is much different from the two
survivors in this study and that her
likelihood of successful resuscitation
is indeed much closer to zero. However, all discussions of ineffectiveness will be based upon probability
statistics. Even the language of the
HDCA is probabilistic in this regard,
stating that “to a reasonable degree
of medical certainty…. the procedure
will not prevent or reduce deterioration or prevent impending death.”
Why do the physicians and
patients, such as the one described in
the case above, disagree on the issue
of Cardiac Resuscitation?
Causes of disagreement between
patient and physician on the
appropriateness of CPR may
be grouped into the following
categories:
1. Lack of patient education about
the actual processes involved during
CPR attempts and about the dismal
outcomes of CPR for patients with
advanced metastatic cancer;
2. Lack of patient opportunity
to participate in advance care
planning, to discuss goals of care and
preferences for end of life care;

3. Distrust of the medical
profession, with the perception that
CPR would be withheld due to cost
control concerns, rather than its
ineffectiveness for the individual;
4. Fear that agreeing to DNR
status is agreeing to a lesser level
of medical attention prior to cardiac
arrest;
5. Belief that a medical breakthrough will occur and a cure will
be achievable if only life can be
extended until that time, thus giving
up CPR is giving up the potential for
living long enough for the medical
breakthrough to occur;
6. Belief that a Divine Miracle
will occur to restore health and
wellness and that declining CPR will
mean not living long enough for the
miracle to become manifest;
7. Use of CPR as a concrete
surrogate for hope, so that giving up
CPR is equated with giving up hope.
Many physicians do not want
to discuss prognosis and “do not
resuscitate” orders with cancer
patients due to a fear of “taking away
the person’s hope.” The clinical
challenge, when caring for patients
facing the end of life, is to present
factual information on prognosis and
what may be expected in the future
while maintaining, but transitioning,
the meaning of hope for individual
patients. Hope at the end of life
still deals with the future, despite a
limited life expectancy. For some,
hope is in the religious belief of a
future afterlife, or simply the hope
of finding peace in death, or going
home in a sense. For others, hope
resides in the future success of the
children and grandchildren and the
Cont. on page 8
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Case Presentation
Cont. from page 7

continuation of the family. Hope
may be found in reconciliation and
forgiveness, and mending broken
relationships, prior to death. One
patient I cared for described her hope
as the transition out of the sadness,
knowing that she would no longer
hear the ocean surf outside her
window, into the joy she found in
knowing that the sounds of the ocean
surf would survive and continue
on despite her absence. For others,
hope may be found in the relief of
pain and having confidence that care
will be present when needed as the
end approaches, the promise of nonabandonment.
Several years ago a patient of
mine was diagnosed with pancreatic
cancer. I performed his preoperative
assessment prior to his Whipple
procedure. After surgery, he enrolled
in various chemotherapy protocols at
the university cancer center and was
lost to my follow up for one year.
Then one day his wife called me in
great distress. He had been dismissed
from the cancer center because he
was no longer responding to any of
the protocols. He had been told to
enroll in hospice. The patient was in
pain and having anorexia, nausea,
vomiting and profound weakness. I
scheduled an urgent house call and
found my patient not only cachectic,
but actually cadaveric in appearance.
He had lost a tremendous amount of
weight, despite having cancer-related
fluid retention and swelling in his
abdomen and legs. He had low blood
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pressure. He was too weak to walk.
He was ashen, pale and jaundiced.
We discussed whether he would
want to return to the hospital or have
me call hospice and try to manage
his symptoms at home. He opted for
hospice care at home. We discussed
cardiac resuscitation status. He was
a retired physician and agreed that
resuscitation would not benefit him
at that point. He expressed his hope
of being able to return to his native
country before he died, though he
realized this was unlikely. Comfort
meds were ordered for the patient at
home and the hospice nurse came
on an urgent basis to enroll him
that same day. As I left the home,
his wife followed me out the door
crying. She asked, “Is there no
hope?” I responded that we could
hope to get his symptoms under
control very quickly and that he
might have some peaceful time with
his family gathered around him for
his final hours or days. That night,
he fell at home. The hospice nurse
came back for an urgent visit. His
breathing had become labored and
the wife was not satisfied with his
response to the comfort meds. She
screamed at the hospice nurse, “Do
something! Save him!” The wife
called 911 and demanded that the
hospice nurse start cardio-pulmonary
resuscitation. When the paramedics
arrived, they called their support
physician and did not continue the
resuscitation efforts. The patient
died at home. When I called the

wife the following day, she said,
“It all just happened so quickly.”
Despite his yearlong illness and slow
decline, she was totally unprepared
for his death. She had, however,
made arrangements for his body to
be returned to his native country for
burial, as was his wish.
Despite our best attempts to help
our patients and their families accept
the inevitability of death, some must
rage against the dying of the light.
Futile CPR attempts are the medical
means of raging against the dying
of the light. Demanding futile CPR
efforts is the last stand of a false
hope. Physicians in Maryland have
the authority to withhold procedures,
including CPR efforts that are
deemed medically ineffective. It is
the duty of our profession, however,
to help prepare our patients and their
families for death through honest,
ongoing discussion and education.
We must help our patients find hope
and integrity at the end of life. We
must stop offering false hopes of
the conquest of our very nature
and humanity, of which death is as
essential and important as birth.
Rebecca D. Elon, MD, MPH
Associate Professor of Medicine
Johns Hopkins University
School of Medicine
Associate Medical Director
Gilchrist Hospice Care

COMMENTS FROM
THE ETHICS
COMMITTEE CHAIR

T

his case, which came to
our ethics consultation
service, raises interesting
questions about the role of an ethics
consultant (individual or team) when
responding to consultation requests.
The patient’s primary physician was
out of town. The covering physician
was adamant that the patient not
receive resuscitative attempts in a
future presentation to the hospital.
How should the ethics consultant
handle such a request? Here is how
our ethics consultation service
responded.
Since the patient had already left
the hospital, it was not possible
to meet with her and discuss the
situation without making a trip to her
home. The question of whether such
a contact would violate HIPPA was
raised, since HIPAA requires that
the use and disclosure of protected
health information be limited to
what is needed in the course of
providing medical care to a patient.
HIPAA notwithstanding, the option
of calling the patient at home was
equally unappealing—imagine
the patient, having just returned
home from the hospital after this
experience, being contacted by a
consultant she did not know/had
not met, nor even been advised of,
wanting to explore these sensitive
matters.

We need to be responsive to
patients, families and care providers
outside of the acute care hospital
setting, given that much of health
care is provided via short term
hospitalization, in outpatient
settings, or ultimately, at home. But,
as in this particular scenario, the
traditional ethics case consultation
approach of meeting the patient
and reviewing the medical record
would have been problematic and
insensitive.
Instead of viewing this as an
emergent ethical dilemma or conflict
between the patient and physician
that needed to be quickly resolved,
the ethics consultant viewed the
situation as non-emergent, and
primarily a communication problem
between the patient and the covering
physician. The patient may have
been unrealistic about her prognosis
and the treatment options available
to her. However, the physician who
requested the ethics consultation
appeared to harbor unrealistic
expectations about how much he
could control other medical care
providers’ actions if the patient
presented to the hospital emergency
department, perhaps overruling the
patient’s wishes and/or violating
EMTALA guidelines.
Given the limitations imposed
by the facts of the case and those
raised by Dr. Elon, our ethics committee took the following actions:

1) We did not try to make contact
with the patient at home.
2) We did not request to see the
patient’s medical record at this time.
3) We contacted the hospital
administration, via the V.P. for
Medical Affairs, to inform them of
the request for an ethics consultation
by a treating physician and to gain
permission to view the patient’s
medical record when/if it became
necessary in the future.
4) We explained to the physician
who requested the ethics consultation
the above considerations, reassuring
him that we value his appreciation of
this treatment dilemma, and invited
him to attend the next monthly
meeting of our hospital Ethics
Consultation Service, where we
would fully discuss this case.
5) We thoroughly apprised the patient’s primary care physician of the
situation at the first opportunity. He
thanked us for the call and promised
to talk with his patient.
What ultimately happened? The
patient entered hospice care and
died a short time thereafter. The
covering physician did not attend our
meeting.
Terry Walman, MD, JD
Anne Arundel Medical Center
Annapolis, MD

.
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NEVER AN ORDINARY DAY:
STRUGGLES OF A PERINATOLOGIST
Reprinted with permission from Atrium: The Report of the Northwestern
Medical Humanities and Bioethics Program, Issue 7, 2009, pp. 26-27.
http://bioethics.northwestern.edu/atrium/

I

prep the room before I call the
family: I enlarge images of
their fetus onto a 24” screen,
I put tissues on the round table,
and I put a plasticene model of a
brain discreetly to the side so I can
describe the pathophysiology of
the defect when the time comes.
The Smiths sit in the waiting room
staring blankly at the TV. Today
they’ve had an ultrasound, fetal
MRI, and fetal echocardiogram. I’m
one of many strangers this couple
has to meet, but our meeting is the
day’s climax, the time when the
pediatric surgeon and perinatologist
(a high-risk obstetrician) will
synthesize and distill all those
test results. They look exhausted
and apprehensive, but they smile
tentatively as I usher them into the
counseling room.
Being a perinatologist is heartbreaking. I love giving my patients
information and answers. It may be
difficult to hear but it gives families
the knowledge, and sometimes even
the strength, to take the next step.
I hate that too often I’m giving the
diagnosis and offering no options.
I’m usually the bearer of bad news,
and only sometimes the bearer of a
tiny life preserver in an otherwise
sinking ship. But now these consults
represent the hope for a middle option that lies between “doing nothing” and termination, the new option
of fetal surgery.
Parents hope invasive fetal therapies will be the “killer app” that
can fix their fetuses. It’s my job to
inform them these technologies and
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procedures aren’t always the solution. Mrs. Smith starts crying, and
tears continue to well up throughout
the entire session. She’s about 20
weeks and the pregnancy isn’t a
threat to her health, so if she wants
to terminate she needs to decide fast.
I ask the Smiths their understanding
of the pregnancy and they speak as a
team, trading sentences.
Everything was fine until a week
ago when we had the ultrasound.
We didn’t want to have any prenatal
testing because we don’t believe in
termination. The technician got quiet
during the ultrasound and seemed
uncomfortable; we could tell something wasn’t right. Then the doctor
came in and told us there was a hole
in the baby’s spine called spina bifida. It seemed like forever before we
could see our OB, and she confirmed
it—our baby will have to wear diapers forever, she’ll have problems
walking, and she might have developmental, behavioral, and mental
issues. There’s pulling on her spinal
cord, so her brain’s affected. We felt
so overwhelmed.
I review the day’s radiologic
findings with the family:
“Ventriculomegaly.”
“Myelomeningocele.”
“L3-L4.”
“Open defect.”

“Closed defect.”
“V-P shunts.”
“Wheelchair.”
“Leg braces.”
“Incontinence.
”
“Intermittent catheterization.”
“Bowel regimen.”
“IQ points.”
“Bell-shaped curves.”
Drawings and a model seem to
help, but I’m still not sure what they
hear. For this family, I sense a lot of
indecision and inner turmoil.
Our doctor asked if we’d be
interested in a repair. Open the
uterus, cover the hole, close the
uterus, and continue the pregnancy?
Our hearts lifted a little.
The pediatric surgeon steps in.
First he focuses on the technical aspects of prenatal surgery, then practical aspects like length of surgery,
recovery time, complications for
mother and fetus, and the absolute
need for cesarean section for delivery. He discusses the research and
outcomes for children with and without in utero surgery. He states that
this surgery is not a cure. It doesn’t
reverse what already has happened,
the fact that the neural tube didn’t

close and the spinal cord has been
exposed to amniotic fluid.
This couple is clearly looking for
a miracle, but at what cost? I want
to be sure Mrs. Smith doesn’t compromise her health unnecessarily,
and that she understands the risks
of what she might be undertaking.
I want to be realistic but hopeful.
I emphasize that the bottom line is
that fetal surgery is still considered
experimental.
I’m uneasy. It’s hard to fathom
the difficulty and enormity of their
decision making. Mrs. Smith’s first
pregnancy had been uncomplicated,
this was going to be a little sister
and their second daughter. After almost five months of carrying a pregnancy with many expectations and
hopes, Mrs. Smith now faces an uncertain future. I present the options
and attempt to be non-directive,
but I don’t think a physician can be
truly objective and non-directive in
counseling. We come to the table
with our own morals and biases, our
own life experiences, and our intimate knowledge of the physiology
and how it impacts normal bodily
functions. We also know about the
worst of the worst scenarios. There
are no guarantees until birth, only a
range of possibilities, and we can’t
predict the impact each one will
have on any particular family. No
matter how many families I counsel,
there is no way of conveying this
intangible aspect. I can’t predict
the future, and I can’t speak to the
social, emotional or financial impact
of their decisions.
So far we’ve been discussing
quality of life in terms of the medical model, fixing physical problems
to fit into society’s understanding of

“normal.” I introduce a discussion
that this fetus and pregnancy could
be another version of functioning
and try to juxtapose the concept of
disability with the focus on correction and cure. It isn’t an easy discussion. The Smiths are quiet as they
look at me; I’m not sure if they hear
me. Their questions about ambulation, incontinence, mental capacity
and school leads me to believe they
are trying to fit this possible reality into their current life, and that
makes sense—the families I see
are generally focused on cure, not
handicap. I’m not so different: years
of medical training have taught me
to think of the human body in terms
of function and repair of function to
normal too.
The mothers I meet will usually
sacrifice their health and body
to achieve a chance of a cure.
Acceptance of the disability
usually isn’t made until after all
curative options are exhausted and
if termination is not an option.
Nevertheless, I feel a need to raise
the “social model of disability” in
this meeting. It may seem odd to
the Smiths, they came to us to hear
about repair. I feel off-kilter myself
since they haven’t made a decision
yet. But if I don’t raise it now, who
will? Most medical offices aren’t
equipped to answer these questions
or provide cogent answers. At the
very least, we can provide resources
and support if the families need
information.
It’s exhausting. These counseling
sessions weigh heavily upon me.
My recommendation and description will influence a family decision
that will alter their lives. I’ve never
met these people before and this is

probably the last time I’ll see them.
I usually get one snapshot of their
lives and family dynamic, and one
chance at a coherent explanation of
what’s going on. These strangers
give me their trust, and in return I
must use the power I hold responsibly and balance the mother and
family’s best interests. But what
does that look like, exactly? I feel
conflicted because the entire day’s
focus is on the problem, its diagnosis and solution. I am not sure how
to shift the focus beyond the “problem” and focus on the child.
Before the Smiths were able to
decide on fetal surgery, that “middle
option” was taken away from them
—they didn’t qualify for the trial
based upon the prenatal diagnostic
images. Maybe that was devastating, maybe having one less decision
to make made it easier—I wish I
knew.
Parents come to me in varying
degrees of understanding and
denial. They come for hope (maybe
the initial diagnosis was incorrect),
for confirmation, and for the
possibility that “something” can be
done. I’ve counseled over a hundred
families, and I still can’t imagine
how my husband and I would react
in the same situation. All I can do
is continue to grapple with this
quandary, and work to help families
come to an understanding that
encompasses all views, so they can
make a truly informed choice.
Serena Wu, MD
Research Fellow in
Fetal Biology and Therapy
Children’s Hospital
of Philadelphia
Philadelphia, PA
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THE PHILOSOPHER'S CORNER:
ALLOCATING SCARCE RESOURCES DURING PANDEMICS

D

uring the recent H1N1
pandemic, a variety
of shortages – ranging
from vaccines and antivirals to
ventilators and ECMO machines1
––have challenged our ability to
provide prevention and treatment
to everyone. Governments,
hospitals, and health-care providers
have confronted difficult questions
about who should receive scarce
medical resources when not all can.
In some cases, federal or state
agencies have proposed or drafted
allocation plans. The Centers for
Disease Control and Prevention
(CDC), for example, recommended
priority access to the H1N1
vaccine for five population groups
at high-risk for complications
from the illness.2 Similarly,
Maryland prepared guidelines for
the distribution of scarce H1N1
antivirals,3 and New York drafted
a scheme for ventilator allocation.4
In many cases, however, decisions
about how to ethically distribute
limited resources during a
pandemic have fallen to hospital
ethics committees and health-care
providers. What criteria should
guide their determinations?
Historically, four allocation
approaches have shaped decisions
about how to ration limited
medical resources. Each one can be
described by the criteria it uses to
select recipients of the scarce good:
(1) social value criteria,
(2) socio-medical criteria,
(3) medical criteria, and
(4) impartial criteria.
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Social value criteria. Of the
four criteria, distributing scarce
resources on the basis of the
potential recipients’ comparative
value to society is the most
controversial. The best-known use
of social value criteria dates back
to 1962, when the Admissions and
Policy Committee of the Seattle
Artificial Kidney Center considered
factors like prospective patients’
net worth, church attendance,
and marital status in determining
whether they ought to receive
access to scarce dialysis machines.5
The Committee was criticized
for, among other things, “playing
God,” reducing people to their
social functions, and violating
equal respect for persons. Today,
ethicists generally eschew social
value criteria, except in rare
circumstances.6
Socio-medical criteria. In
contrast to social value criteria,
which accord preference to
prospective patients based on
characteristics that have no bearing
on medical outcomes, sociomedical criteria grant priority status
to prospective patients based on
social and personal characteristics
that arguably do impact health
outcomes. Among other traits,
socio-medical criteria may include
a person’s age, lifestyle, mental
health, history of responsible
behavior, and likelihood of
complying with medical regimens.
Socio-medical criteria have
gained some traction in modern
medicine, particularly in the
context of organ transplantation

policy. People with strong social
support systems––and who are
young, psychologically stable,
and medically responsible––are
considered “better” candidates
for organ transplantation than
those who do not possess these
characteristics. Applying sociomedical criteria to determine
allocation can, however, deprive
some people of fair and equal
access opportunities. For that
reason, medical or impartial criteria
(discussed below) often are viewed
as more ethically sound approaches
to distributing scarce resources.7
Medical criteria. The American
Medical Association’s (AMA)
Code of Ethics recommends
medical criteria as the “only
ethically appropriate criteria”
for allocating limited medical
resources.8 Accordingly, allocation
decisions can consider the
prospective patient’s “likelihood
of benefit, urgency of need, change
in quality of life, duration of
benefit, and, in some cases, the
amount of resources required for
successful treatment.”9 Medical
criteria inform the CDC’s
H1N1 vaccination scheme,
which recommends vaccinating
populations at the highest risk for
H1N1-related illness first.10 New
York’s ventilator allocation plan,11
which provides ventilator access
to patients who “have the greatest
medical need—and the best
chance of survival—if they receive
ventilator support,” also employs
medical criteria.

Impartial criteria. The AMA
Code of Ethics suggests that when
there are not significant differences
between patients on the basis of
medical criteria, resources should
be allocated randomly among
eligible candidates. There are
a variety of equal-opportunity
creating mechanisms, including
queuing (first-come-first-served)
and chance (lottery) systems.
During the 2004 flu season,
queuing and lotteries were used
to distribute the flu vaccine,
which was in short supply due
to production mishaps. Limited
supplies of drugs to treat AIDS
have been similarly distributed to
patients.12 Advocates of impartial
allocation highlight the fact that
it treats all persons fairly and
equally.13 Detractors “contend that
the use of impersonal mechanisms
reflects an irresponsible refusal to
make a decision,”14 and that the
mechanisms themselves can create
unintentional injustices.15
Hospitals and ethics committees
have adopted a variety of
approaches to allocating scarce
resources during the H1N1
pandemic. It is still too early
to determine which criteria are
in greatest use, though early
evidence suggests a preference
for medical criteria.16 Regardless,
it is important to note that these
criteria require careful application
and transparent execution. Reports
suggest that the H1N1 flu season
may be ending, but conversations
about how to ethically steward our
scarce resources must continue.
Leslie Meltzer Henry
Assistant Professor of Law
University of Maryland
School of Law
Baltimore, MD

NOTES
ECMO stands for Extracorporeal
Membrane Oxygenation. It is a
form of cardiac and respiratory support for a patient whose heart and
lungs are not functioning properly.
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CDC, 2009 H1N1 Vaccination
Recommendations (2009), available
at http://www.cdc.gov/h1n1flu/vaccination/acip.htm.
2
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Code of Medical Ethics §2.03,
http://www.ama-assn.org/ama/pub/
physician-resources/medical-ethics/
code-medical-ethics/opinion203.
shtml.
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See supra note 2.
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Maryland Department of Health
and Mental Hygiene, Pandemic
Influenza Response Annex (Version
7.3, 2009), available at http://bioterrorism.dhmh.state.md.us/Docs/PandemicInfluenza/PandemicInfluenzaR
esponseAnnex(Version7.3).pdf.
3

New York State Working Group on
Ventilator Allocation in an Influenza
Pandemic, Allocation of Ventilators
in a Pandemic: Planning Document
(2007), available at http://www.
health.state.ny.us/diseases/communicable/influenza/pandemic/ventilators/docs/ventilator_guidance.pdf.
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Shana Alexander, “They Decide
Who Lives, Who Dies,” 53 Life
102-125 (1962).

New York State Department of
Health and the New York State
Task Force on Life & the Law, New
York State Workgroup on Ventilator
Allocation in an Influenza Pandemic
(2007), http://www.ama-assn.org/
ama1/pub/upload/mm/415/new_
york_state.pdf.
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During World War II, scarce doses
of penicillin were administered
to soldiers who had contracted
venereal diseases rather than
soldiers who had infected battle
wounds. The rationale was that the
former could return to the battlefield
more rapidly. Tom L. Beauchamp
and James F. Childress, Principles
of Biomedical Ethics 270 (5th ed.
2001).
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For example, the rule of firstcome-first-served can raise questions about whether patients already
receiving treatment have priority
over prospective patients who arrive later but may have either more
urgent medical needs or a better
prognosis with treatment.
In particular, many hospitals
are adopting a clinical algorithm,
known as SOFA scoring, for
allocating limited resources on the
basis of standard medical criteria.
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CALENDAR OF EVENTS
MARCH
17

(12:15 PM – 1:15 PM) Howard B. Mayes’ lecture in ethics. Speaker: Danielle Aubrey, MD.
University of Maryland Medical Center, Shock Trauma Auditorium, 22 S. Greene St., Baltimore,
MD. For more information, contact Henry Silverman at hsilverm@medicine.umaryland.edu.

26

“Health Law and the Elderly: Managing Risk at the End of Life,” sponsored by the Widener
Law Review, in partnership with the Widener University School of Law Health Law Institute,
Delaware Hospice, the Delaware End-of-Life Coalition, at the Ruby Vale Courtroom on
Widener’s Wilmington, Delaware campus. For more information, visit http://widenerlawreview.
org/?page_id=329 or contact Thaddeus Pope at tmpope@widener.edu.

APRIL
6

(4:00 PM – 6:00 PM) Seminar Speaker: Stephen Latham, JD, PhD, Deputy Director,
Interdisciplinary Center for Bioethics, Yale University. Sponsored by the University of
Pennsylvania Center for Bioethics, 3401 Market St, Suite 331, Philadelphia, PA. For more
information, visit http://bioethics.upenn.edu/Colloquium.shtml. To RSVP, e-mail
jpringle@mail.med.upenn.edu or call 215-898-7136.

8

(12:00 noon) “Futility: What’s a Doctor to Do?” Grand Rounds, Shady Grove Adventist
Hospital. Speaker: Paul S. Van Nice, MD, PhD, MA. Complimentary lunch. Birch/Sycamore
Conference Rooms, Shady Grove Adventist Hospital, 9901 Medical Center Drive, Rockville,
MD 20850. For more information, contact paul@vannice.com.

12

(12:15 PM – 1:15 PM) Rives Hutzler Lecture: Speaker, Alan Fleischman, MD, Senior Vice
President, New York Academy of Medicine. Sponsored by the Berman Institute of Bioethics,
Johns Hopkins University, 615 N. Wolfe Street, W3008. For more information, visit http://www.
bioethicsinstitute.org/, or contact Michelle Martin-Daniels at atmmartind@jhsph.edu.

12

(5:30PM - 7:00PM) “Medical Miracles: Doctors, Saints and Healing in the Modern World,”
the John K. Lattimer Lecture. Speaker: Jacalyn Duffin, MD, PhD, Queen’s University.
Sponsored by the New York Academy of Medicine, 1216 Fifth Avenue, New York, NY. For
more information, visit http://www.nyam.org/events/.

19

“Health Care Ethics in the 21st Century,” Providence Health Care’s 2nd Annual Health Ethics
Seminar, Conference Centre, 2nd Floor, 1190 Hornby St, Vancouver, BC. For more information,
visit http://www.providencehealthcare.org/ethics_services/, e-mail jmonthatawil@providence
health.bc.ca, or call 604-806-9952.

19-20 “Recognizing and Managing Moral Distress in Rehabilitation Health Care.” Sponsored by the
Rehabilitation Institute of Chicago, Chicago, IL. For more information, visit http://www.ric.org/
education.
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22-24 “Pediatric Ethics 2010: Advancing the Interests of Children,” sponsored by the Northern Ohio
Regional Pediatric Ethics Consortium. Cleveland Renaissance, Cleveland, OH. For more
information, visit www.ccfcme.org/PediatricEthics10, or contact Kathryn Wiese at
WEISEK@ccf.org.
26

(12:15 PM – 1:15 PM) Berman Institute of Bioethics Lunch Seminar Series Speaker: Karen
Rothenberg, JD, MPA, Marjorie Cook Professor of Law, University of Maryland School of Law,
Visiting Faculty, Johns Hopkins Berman Institute of Bioethics. Sponsored by the Berman Institute
of Bioethics, Johns Hopkins University, 615 N. Wolfe Street, W3008. For more information, visit
http://www.bioethicsinstitute.org/, or contact Michelle Martin-Daniels at atmmartind@jhsph.edu.

10

(12:15 PM – 1:15 PM) Berman Institute of Bioethics Lunch Seminar Series Speaker: Peter
Whitehouse, MD, PhD, Professor of Neurology, Case Western Reserve University. Sponsored by
the Berman Institute of Bioethics, Johns Hopkins University, 615 N. Wolfe Street, W3008,
Baltimore, MD. For more information, visit http://www.bioethicsinstitute.org/, or contact Michelle
Martin-Daniels at atmmartind@jhsph.edu.

28

“Disability, Health Care, and Clinical Ethics—What Really Matters.” Co-sponsored by MHECN
and Kennedy Krieger Institute, at Thomas B. Turner Building, Johns Hopkins University
School of Medicine, 720 Rutland Avenue, Baltimore, MD. For more information and to register
online, visit http://www.law.umaryland.edu/mhecn (click on “conferences”). Or e-mail
MHECN@law.umaryland.edu.

29

(10:30AM – 12:30 PM) “A Deeper Diversity, The Nation’s Health: Renewing Social Justice
and Human Well-Being in Our Time.” Sponsored by the Office of Sponsored Projects of the
Smithsonian Institution in partnership with the Navy Medicine Institute for the Medical
Humanities and Research Leadership. National Museum of American History, Smithsonian
Institution, Washington, DC. For more information, visit http://www.thechiefinformationgroup.
com/conference/smithsonian/index.php?c_id=12, or contact Julie O'Dell at O'DellJ@si.edu.

MAY
6-7

“Intensive Workshop in Healthcare Ethics” Sponsored by the University of Arkansas Medical
System, Little Rock, AR. For more information, visit http://www.uams.edu/humanities/HCE2010.asp, or contact Carol VanPelt at vanpeltcarola@uams.edu.

11-14 “6th International Conference on Clinical Ethics Consultation” (ICCEC), Portland, OR. For more
information, visit http:// www.ethics2010.org.
13

(4:00 PM – 6:00 PM) Seminar Speaker: Rita Charon, MD, PhD, Professor of Clinical Medicine,
Director, Program in Narrative Medicine, College of Physicians and Surgeons of Columbia
University. Sponsored by the University of Pennsylvania Center for Bioethics, 3401 Market St,
Suite 331, Philadelphia, PA. For more information, visit http://bioethics.upenn.edu/Colloquium.
shtml. To RSVP, e-mail jpringle@mail.med.upenn.edu or call 215-898-7136.

21-22 “Disability and Ethics through the Life Cycle: Cases, Controversies, & Finding Common Ground.”
Sponsored by Albany Law School, the Rapaport Ethics Across the Curriculum Program of Union
College, and the Bioethics Program of Union Graduate College and the Mount Sinai School of
Medicine. Union College, Schenectady, NY. For more information, contact blooma@union.edu or
noltea@uniongraduatecollege.edu.
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